EUVIMEDEUVIMED entdecken
Crossref

Trifarotene 0.005% Cream: A Novel Topical Retinoid as a Monotherapy in Mild to Moderate Facial Acne Vulgaris in Egyptian Patients

The Egyptian Journal of Hospital Medicine · 01.04.2026 · 103 (1) · 2186-2191

DOI: 10.21608/ejhm.2026.501048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Egyptian Journal of Hospital Medicine, online erschienen am 01.04.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Trifarotene 0.005% Cream: A Novel Topical Retinoid as a Monotherapy in Mild to Moderate Facial Acne Vulgaris in Egyptian Patients. The Egyptian Journal of Hospital Medicine, 103(1), 2186-2191. https://doi.org/10.21608/ejhm.2026.501048

Vancouver

Trifarotene 0.005% Cream: A Novel Topical Retinoid as a Monotherapy in Mild to Moderate Facial Acne Vulgaris in Egyptian Patients. The Egyptian Journal of Hospital Medicine. 2026;103(1):2186-2191. doi:10.21608/ejhm.2026.501048

BibTeX
@article{euvimed2026,
  title = {Trifarotene 0.005% Cream: A Novel Topical Retinoid as a Monotherapy in Mild to Moderate Facial Acne Vulgaris in Egyptian Patients},
  journal = {The Egyptian Journal of Hospital Medicine},
  year = {2026},
  volume = {103},
  number = {1},
  pages = {2186--2191},
  doi = {10.21608/ejhm.2026.501048}
}
Kostenlos starten →